Abstract
Hymenoptera venom anaphylaxis (HVA) is reported in 0.3-3% of stings and accounts for approximately 40 US deaths annually. HVA patients require immediate availability of epinephrine and Allergist referrals for consideration of venom immunotherapy. Data regarding epinephrine autoinjector prescriptions, Allergist referral rates, and potential racial disparities are limited.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have